» Authors » Ryoichi Goto

Ryoichi Goto

Explore the profile of Ryoichi Goto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 681
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Forgioni A, Watanabe M, Goto R, Harada T, Ota T, Shimamura T, et al.
Cell Transplant . 2025 Feb; 34:9636897251317887. PMID: 39981681
Pancreatic islet transplantation (PITx) is a promising treatment option for patients with type 1 diabetes mellitus. Previously, we demonstrated that therapy with alloantigen-specific immunomodulatory cells (IMCs) generated in the presence...
2.
Shimamura T, Watanabe M, Koshizuka Y, Goto R, Kawamura N, Orimo T, et al.
Surg Case Rep . 2024 Dec; 10(1):274. PMID: 39630322
Background: In patients with pancreaticobiliary maljunction complicated by congenital biliary dilatation, the pancreatic enzyme flows back into the bile, leading to bile duct carcinogenesis. Although the biliary tract resection and...
3.
Honda S, Kawakita I, Okumura K, Ara M, Goto R, Takeda A, et al.
J Paediatr Child Health . 2024 Aug; 60(10):606-609. PMID: 39105396
No abstract available.
4.
Kanazawa R, Goto R, Harada T, Ota T, Kobayashi N, Shibuya K, et al.
Scand J Immunol . 2024 Jul; 100(4):e13397. PMID: 39080853
Graft-infiltrating lymphocytes (GILs) play an important role in promoting rejection after organ transplantation. We recently reported that GILs that accumulated up to 3 days post-transplantation did not promote rejection, whereas...
5.
Ota T, Goto R, Harada T, Forgioni A, Kanazawa R, Ganchiku Y, et al.
Immunohorizons . 2024 Apr; 8(4):295-306. PMID: 38587418
The non-Fc-binding anti-CD3 Ab [anti-CD3F(ab')2] can induce graft acceptance depending on the therapeutic window in a rodent heart transplant model. The delayed protocol allows for early graft infiltration of lymphocytes,...
6.
Toshida K, Itoh S, Toshima T, Yoshiya S, Goto R, Mita A, et al.
Ann Gastroenterol Surg . 2024 Jan; 8(1):163-171. PMID: 38250695
Background: There is limited published information regarding the expression of mechanistic target of rapamycin (mTOR) in vessels that encapsulate tumor cluster (VETC)-positive hepatocellular carcinoma (HCC). The mTOR inhibitor, everolimus, has...
7.
Goto R, Kawamura N, Watanabe M, Ganchiku Y, Nagatsu A, Okada K, et al.
Ann Gastroenterol Surg . 2023 Jul; 7(4):645-653. PMID: 37416731
Aim: Approximately 30 years have passed since the first experience of living donor liver transplantation. The time to evaluate the long-term safety of living donors has been fulfilled. Meanwhile, nonalcoholic...
8.
Goto R, Fukasaku Y, Ganchiku Y, Kawamura N, Watanabe M, Ota T, et al.
Front Pediatr . 2023 May; 11:1172516. PMID: 37181419
The roles of post-transplant anti-HLA donor specific antibody (DSA) in pediatric liver transplantation (LT), including therapeutic strategies, remain controversial. This study aimed to identify the risks of post-transplant DSA for...
9.
Wakui Y, Goto R, Watanabe M, Kawamura N, Ogawa K, Mitsuhashi T, et al.
Nihon Shokakibyo Gakkai Zasshi . 2022 Dec; 119(12):1096-1102. PMID: 36504102
A 15-year-old female patient was diagnosed with a fulminant-type Wilson's disease. She had severe illness with a Model for End-Stage Liver Disease score of 25 and new Wilson Index score...
10.
Hidaka M, Eguchi S, Hasegawa K, Shimamura T, Hatano E, Ohdan H, et al.
Hepatol Res . 2022 Aug; 53(1):18-25. PMID: 36002995
Aim: Human immunodeficiency virus (HIV)/hepatitis C virus (HCV) co-infection from blood products for hemophilia has been a social problem in Japan, and liver transplantation (LT) for these patients has been...